Literature DB >> 11225794

Internal low-energy cardioversion: a therapeutic option for restoring sinus rhythm in chronic atrial fibrillation after failure of external cardioversion.

V Taramasco1, A Socas, P Ricard, S Lévy.   

Abstract

AIMS: Conventional external cardioversion remains the technique of choice for restoration of sinus rhythm in patients with chronic atrial fibrillation (AF). Recent reports have suggested that internal low-energy cardioversion is efficient and safe in terminating AF in patients with failed external cardioversion. METHODS AND
RESULTS: In 20 of 118 consecutive patients with spontaneous chronic AF (>7/days), who underwent low-energy cardioversion, one or more attempts at restoring sinus rhythm with external cardioversion had failed. Low-energy internal cardioversion was performed under light sedation. Shocks were delivered (using an external custom defibrillator) between two nonapolar catheters positioned in the right atrium (cathode) and in the coronary sinus (anode). Heart disease was present in 12 and absent in eight patients ('lone' atrial fibrillation). Atrial fibrillation was established for a period ranging from 12 days to 53 months. Low-energy internal cardioversion restored sinus rhythm in 15 of the 20 patients (75%) with a mean energy of 4.5+/-1.2 J, a mean conversion voltage of 355+/-53 V and a mean impedance of 63+/-8 ohms. No complications were observed. With a mean follow-up of 6+/-7 months, 11 patients (73%) were in stable sinus rhythm.
CONCLUSIONS: This study provides evidence in support of low-energy internal cardioversion as a valuable therapeutic option in patients in whom conventional external cardioversion failed. This technique is safe and does not require general anaesthesia.

Entities:  

Mesh:

Year:  1999        PMID: 11225794     DOI: 10.1053/eupc.1999.0035

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  6 in total

1.  Internal atrial and ventricular defibrillation during electrophysiology procedures.

Authors:  Fred M Kusumoto
Journal:  J Interv Card Electrophysiol       Date:  2005-08       Impact factor: 1.900

2.  Rate of conversion and recurrence after sotalol treatment in patients with direct current-refractory atrial fibrillation.

Authors:  Anna Nergärdh; Rolf Nordlander; Mats Frick
Journal:  Clin Cardiol       Date:  2006-02       Impact factor: 2.882

3.  Evaluating the Efficacy and Safety of Internal Cardioversion with Implantable Cardioverter Defibrillator Device for Atrial Fibrillation in Systolic Heart Failure Patients.

Authors:  Hamza Sunman; Kudret Aytemir; Hikmet Yorgun; Uğur Canpolat; Muhammet Ulvi Yalçin; Naresh Maharjan; Serkan Asil; Levent Şahiner; Barış Kaya; Necla Özer; Ali Oto
Journal:  Ann Noninvasive Electrocardiol       Date:  2015-06-18       Impact factor: 1.468

Review 4.  Present treatment options for atrial fibrillation.

Authors:  S K S Lairikyengbam; M H Anderson; A G Davies
Journal:  Postgrad Med J       Date:  2003-02       Impact factor: 2.401

5.  Predictors of atrial fibrillation recurrence in patients with long-lasting atrial fibrillation.

Authors:  Michalis Efremidis; Ioannis P Alexanian; Dimitrios Oikonomou; Dimitrios Manolatos; Konstantinos P Letsas; Loukas K Pappas; Gerasimos Gavrielatos; Maria Vadiaka; Constantinos C Mihas; Gerasimos S Filippatos; Antonios Sideris; Fotios Kardaras
Journal:  Can J Cardiol       Date:  2009-04       Impact factor: 5.223

6.  Internal cardioversion of persistent atrial fibrillation using rectilinear biphasic waveform.

Authors:  Georges H Mairesse; Monique Raepers; Isabelle Legrand; Imad Baroud; Yvon Deheneffe; Michel Emonts; Jean-Louis Paquay; Kamal Mitri
Journal:  J Interv Card Electrophysiol       Date:  2003-12       Impact factor: 1.900

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.